Aromatic Quinolinecarboxamides as Selective, Orally Active Antibody Production Inhibitors for Prevention of Acute Xenograft Rejection
- 12 May 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (12), 1986-1992
- https://doi.org/10.1021/jm010822m
Abstract
The prevention of xenograft rejection is substantially dependent on inhibiting antibodies (Ab) produced by B-cells independently of T-cell signals (TI-1). Due to their ubiquitous biochemical mechanisms of action, the immunosuppressants currently employed not only fail to discriminate between B- and T-cells but also have a narrow therapeutic window and, thus, their prolonged use in complex immunosuppressive regimens is problematic. By capitalizing on the target enzyme-bound (DHODH) structure 1b of one of these compounds, leflunomide, and modulating part of its multiple mechanisms of action to gain selectivity, the quinoline-8-carboxamide 3 was designed as a potentially weak enzyme inhibitor but effective immunosuppressant. Compound 3 fulfilled the mechanistic criteria set and had 10-fold B-cell over T-cell selectivity. Its pyridyl analogue 4 was found to be a highly potent and selective B-cell immunosuppressant with a 75-fold selectivity for B- over T-cells (as judged by the MLR data) and no general cytotoxicity at concentrations up to 160-fold higher than those required to inhibit B-cells. In the mouse, 4 effectively blocked TI-1 Ab production and suppressed Ab-mediated xenograft rejection in a xenotransplantation model under a once-daily dosing regimen, with efficacy down to 0.3 mg/kg/day po. These are the first data demonstrating the feasibility of the development of drugs specific for impeding Ab production.Keywords
This publication has 12 references indexed in Scilit:
- Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activationTransplantation Proceedings, 2001
- Paper AlertStructure, 2000
- SUPPRESSION OF DELAYED XENOGRAFT REJECTION BY SPECIFIC DEPLETION OF ELICITED ANTIBODIES OF THE IgM ISOTYPE1Transplantation, 1999
- T cell response in xenorecognition and xenografts: a reviewHuman Immunology, 1999
- Progress in xenotransplantationExpert Opinion on Investigational Drugs, 1999
- Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agentsExpert Opinion on Therapeutic Patents, 1999
- Pyrazole Bioisosteres of Leflunomide as B-Cell Immunosuppressants for Xenotransplantation and Chronic Rejection: Scope and LimitationsJournal of Medicinal Chemistry, 1998
- Leflunomide's Bioactive Metabolite Has the Minimal Structural Requirements for the Efficient Inhibition of Human Dihydroorotate DehydrogenaseBioorganic Chemistry, 1997
- 2-(Trifluoromethyl)quinolines from anilines: A novel mode of isomerization and cyclizationTetrahedron, 1996
- A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain geneNature, 1991